1.
Jain P, Romo CG, Khoury HJ, Kantarjian H, Cortes J. Clinical activity of ponatinib in patients with chronic myeloid leukemia in chronic phase with e1a2 transcripts. Haematologica 2013; 98(11):e141-e142; https://doi.org/10.3324/haematol.2013.092882.